SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Codatta

XNY (Codatta) is a focal point of discussion following recent strong price action, including significant rallies that saw it outperform broader market pullbacks, leading many in the community to actively buy dips and anticipate further parabolic moves. While some warn of pump-and-dump characteristics, supporters are bullish on its potential as an AI data future project and its current technical strength.

SSgA Active Trust - State Street Utilities Select Sector SPDR ETF

Utilities Select Sector SPDR Fund

The Utilities Select Sector SPDR Fund is gaining traction as a critical beneficiary of increasing energy demand from AI data centers, attracting investors seeking both growth potential and defensive stability amidst broader market shifts.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending due to its exceptionally active and resilient community, which consistently emphasizes long-term conviction, strategic accumulation, and the ongoing expansion of its 'permissionless brand' through numerous real-world product initiatives and upcoming community celebrations, despite prevailing market conditions.

Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SNÅP, enables the rapid and precise refinement of structural design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.

Tyra Biosciences Inc

Tyra Biosciences is trending due to recent FDA clearance for its Phase 2 study of TYRA-300 in pediatric achondroplasia, alongside strong analyst coverage highlighting multi-billion-dollar potential for its precision FGFR3 inhibitor across oncology and rare disease indications. The community is actively discussing TYRA-300's "best-in-class" prospects and upcoming clinical catalysts anticipated to further de-risk the story.

Ethena

A major capital raise by StableCoinX for its ENA accumulation strategy, coupled with a significant buyback program from the Ethena Foundation, is driving bullish sentiment around Ethena's synthetic dollar USDe. The community is actively discussing growing institutional interest and the token's potential for substantial upside, further amplified by its recent Robinhood listing.

Daktronics, Inc. engages in designing and manufacturing electronic scoreboards, programmable display systems and large screen video displays for sporting, commercial and transportation applications. It operates through the following segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The Commercial segment sells video, display systems, digital billboards, Galaxy, and Fuelight product lines to resellers, out-of-home companies, national retailers, quick-serve restaurants, casinos, shopping centers, cruise ships, commercial building owners, and petroleum retailers. The Live Events segment provides scoring and video display systems to college and professional sports facilities and convention centers and the sale of mobile display technology to video rental organizations and other live events type venues. The High School Park and Recreation segment engages in the sale of scoring systems, Galaxy displays, and video display systems to primary and secondary education facilities. The Transportation segment consists of sales of Vanguard and Galaxy product lines to governmental transportation departments, airlines, and other transportation related customers. The International segment is composed of sales of all product lines outside the United States and Canada. The company was founded by Aelred J. Kurtenbach and Duane E. Sander in 1968 and is headquartered in Brookings, SD.

Daktronics Inc.

Daktronics is trending following strong earnings beats, robust order and sales growth, and an increased share buyback authorization, which collectively underscore improving financial health and operational momentum. The community is noting its expanding product backlog and long-term growth objectives, with discussions drawing parallels to other companies that saw significant gains after resolving prior internal control challenges.

Tidal Trust II - Defiance Nasdaq 100 Weekly Distribution ETF

Defiance Nasdaq 100 Target 30 Income ETF

QQQY is actively trending due to its consistent high weekly dividend payouts, stemming from its 0DTE options strategy on the Nasdaq 100. The community is focused on evaluating these significant income distributions against concerns about potential NAV erosion and the impact of its recent reverse split, with many investors using it to build passive income streams.

Peabody Energy Corp. engages in the business of coal mining. It operates through the following business segments: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal, and Corporate and Other. The Seaborne Thermal segment consist of mines in New South Wales, Australia. The Seaborne Metallurgical segment includes mines in Queensland, Australia, one in New South Wales, Australia and one in Alabama, USA. The Powder River Basin segment focuses on mines in Wyoming. The Other U.S. Thermal segment reflects on the mining, preparation and sale of thermal coal, sold primarily to electric utilities in the U.S. under long-term contracts, with a relatively small portion sold as international exports as conditions warrant. The Corporate and Other segment involves administrative expenses, results from equity method investments, trading and brokerage activities, minimum charges on certain transportation-related contracts, the closure of inactive mining sites, the impact of foreign currency remeasurement and certain commercial matters. The company was founded by Francis S. Peabody in 1883 and is headquartered in St. Louis, MO.

Peabody Energy Corp. - Ordinary Shares New

Peabody Energy is trending as the market responds to the Trump administration's new pro-coal policies, including directives for federal coal purchases and eased environmental regulations. Investors are also actively discussing the company's perceived undervaluation and the strategic upside from recent rare earth element discoveries within its coal assets.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as investors anticipate its Q4 earnings and a crucial presentation on same-day Rolvedon dosing, with community sentiment underscoring the company's significant undervaluation against its strong cash position and product pipeline, as it navigates Nasdaq compliance and potential strategic acquisitions.

Vital Farms, Inc. packages, markets and distributes pasture-raised shell eggs, pasture-raised butter and other products. Its products are sold under the trade names Vital Farms, Alfresco Farms, Lucky Ladies and RedHill Farms, primarily to retail foodservice channels. The company was founded by Catherine Stewart, Matthew O'Hayer and Jason Jones in 2007 and is headquartered in Austin, TX.

Vital Farms Inc

Vital Farms is generating buzz after consistently exceeding earnings expectations and raising guidance, which has led to numerous analyst upgrades and intensified community discussion around its growth prospects and potential for a short squeeze given its high short interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE

Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group...

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit...

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit SKYE Deadline: SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud...

Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm

Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026 Deadline to Join - Contact The Gross Law Firm Class Action Filed Against Skye Bioscience, Inc. (SKYE) - January 16, 2026...

SKYE Deadline: Rosen Law Firm Urges Skye Bioscience, Inc. (NASDAQ: SKYE) Stockholders to Contact the Firm for Information About Their Rights

Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Skye Bioscience, Inc. (NASDAQ: SKYE) between November 4, 2024 and October 3, 2025. Skye is a clinical stage...

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE

Skye Bioscience, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before January 16, 2026 to Discuss Your Rights - SKYE Skye Bioscience, Inc. Securities Fraud Class...

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK...

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm PR Newswire NEW YORK, Jan. 6, 2026 NEW YORK...

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience

INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Skye Bioscience...

Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion. The company was founded on March 16, 2011 and is headquartered in San Diego, CA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.30	-$0.24	19.22%	BEAT
Q3 '25	-$0.31	-$0.32	-1.99%	MISSED
Q2 '25	-$0.31	-$0.44	-41.51%	MISSED
Q1 '25	-$0.29	-$0.28	2.42%	BEAT
Q4 '24	-$0.28	-$0.24	13.80%	BEAT

SKYE
Skye Bioscience Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest SKYE News

SKYESkye Bioscience Inc